Table 2.
Baseline Characteristics of Women and Men With Baseline Measurement of TSH Levels: Cardiovascular Health Studya
| Baseline Characteristics | Men
|
Women
|
||||
|---|---|---|---|---|---|---|
| Subclinical Hyperthyroidism (n = 29) | Euthyroidism (n = 1159) | Subclinical Hypothyroidism (n = 184) | Subclinical Hyperthyroidism (n = 142) | Euthyroidism (n = 1694) | Subclinical Hypothyroidism (n = 359) | |
| TSH, mean (SD), mIU/L | 0.22 (0.15) | 2.08 (0.96) | 6.66 (2.57) | 0.17 (0.12) | 2.26 (1.02) | 6.78 (2.58) |
| Thyroid hormone medication | 11 (37.9) | 31 (2.7) | 6 (3.3) | 108 (76.1) | 114 (6.7) | 34 (9.5) |
| T4 | 7 (63.6) | 24 (77.4) | 5 (83.3) | 72 (66.7) | 84 (73.7) | 29 (85.3) |
| T3 | 0 | 0 | 0 | 2 (1.9) | 0 | 0 |
| T4 and T3 | 4 (36.4) | 7 (22.6) | 1 (16.7) | 34 (31.5) | 29 (25.4) | 4 (11.8) |
| Unknown type | 0 | 0 | 0 | 0 | 1 (0.9) | 1 (2.9) |
| Antithyroid or corticosteroid medicationb | 2 (6.9) | 32 (2.8) | 3 (1.6) | 8 (5.6) | 41 (2.4) | 5 (1.4) |
Abbreviations: T3, triiodothyronine; T4, thyroxine; TSH, thyrotropin.
a
Unless otherwise indicated, data are expressed as number (percentage) of participants.
b
One woman with subclinical hypothyroidism took antithyroid medication, and the rest took corticosteroid medication.